Advances in Oligonucleotide Synthesis Market Pave Way to Longer Molecules of High Fidelity, Global Valuation to Rise at CAGR of 9.5% from 2019 to 2027
- Research application to be a highly lucrative segment, and demand for customized oligonucleotides for therapeutics and diagnostics applications to rise at rapid pace, where DNA oligonucleotides and RNA oligonucleotides are extensively-used segment
- Big strides in life-sciences industry make North America a prominent regional market, global market to reach US$ 4,511.3 Mn by 2027-end
ALBANY, N.Y., Oct. 6, 2020 /PRNewswire/ -- Advances made in the chemistries of synthesis of oligonucleotide have spurred its prospects in research, and numerous commercial biotech and life-sciences applications. Biotech and pharmaceutical companies expending on research to develop molecules of higher fidelity and longer molecules.
The global oligonucleotide synthesis market was pegged at US$ 1,966.2 Mn in 2018, and is projected to expand at CAGR of 9.5% from 2019 to 2027. A number of molecular biology applications will expand the revenue potential for players in the market.
Key Findings of Oligonucleotide Synthesis Market Report
Synthesized oligonucleotides are the dominant product segment in 2018
The aforementioned segment is expected to retain its dominance during the assessment period of 2019 – 2027
Of the various applications, research is the leading segment in 2018
During the forecast period, therapeutics application segment is expected to be a highly lucrative one
North America was the leading geographical market in 2018
Europe was the second-leading one in the global oligonucleotide synthesis market
Oligonucleotide Synthesis Market: Key Driving Factors and Promising Avenues
Large strides have been made in the chemical synthesis of oligonucleotides that can be tailored to meet the applications in biotech and life-sciences industries. The rapid uptake in these applications is driving revenues in the global oligonucleotide synthesis market.
Various pharmaceutical and biotechnology companies have unlocked advanced organic chemistry to develop molecules of high yield, purity, and fidelity. This has been broadening the prospect of oligonucleotides in research application.
Growing demand for oligonucleotides and their analogies in combinatorial technology is expected to open several new revenue streams for stakeholder in the oligonucleotide synthesis market.
Rise in research and development of polymerase chain reaction, and next generation sequencing is boosting the growth of the oligonucleotide synthesis market.
Leaning of players to develop personalized medicine has stimulated biotech players seek oligonucleotides with new characteristics, thereby boosting the oligonucleotide synthesis market.
Expanding the drug pipelines consisting of RNAi therapeutic drugs has bolstered the generation of new opportunities in the market.
Explore 187 pages of top-notch research, incisive insights, and detailed country-level projections on Oligonucleotide Synthesis Market (Product - Reagents & Consumables, Equipment, and Synthesized Oligonucleotides (DNA Oligonucleotides and RNA Oligonucleotides); Application - Research (Polymerase Chain Reaction and Next Generation Sequencing), Therapeutics (Antisense Oligonucleotides, and Nucleic Acid Aptamers), and Diagnostics; End User - Biotechnology & Pharmaceutical Companies, Research Institutes, and Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027 at https://www.transparencymarketresearch.com/report-toc/11804
Key Impediments to Oligonucleotide Synthesis Market Stakeholders
Despite the vast strides being made in the chemistries of organic molecules, the synthesis of oligonucleotide of longer chains and of good fidelity is difficult. There are significant risks of side effects, which heavily limit the commercial production of oligonucleotide of remarkable length. However, in coming years, researchers will be leaning on adopting new approaches pertaining to research and development of the synthesis of RNA analogs.
Geographically, North America is a substantially lucrative market. Tens of scores of oligonucleotides are undergoing clinical trials in the U.S. Over the past few years, large strides have been made in life-sciences and biotech sectors, spurring the adoption of newly synthesized oligonucleotides. Rise in uptake in molecular biology application is also boosting the growth in the North America oligonucleotide synthesis market.
On the other hand, Asia Pacific is showing remarkable revenue potential. The demand for new biotechnology molecules and research in personalized medicine will fuel the revenue potential of this regional market in coming years.
The Oligonucleotide Synthesis Market can be segmented as follows:
Global Oligonucleotide Synthesis Market, by Product Type
Reagents & Consumables
Global Oligonucleotide Synthesis Market, by Applications
Polymerase Chain Reaction
Next Generation Sequencing
Nucleic Acid Aptamers
Global Oligonucleotide Synthesis Market, by End User
Biotech & Pharma Companies
Global Oligonucleotide Synthesis Market, by Region
Rest of Europe
Australia & New Zealand
Rest of Asia Pacific
Rest of Latin America
Middle East & Africa
Rest of Middle East & Africa
Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:
Analytical Standards Market: According to Transparency Market Research's latest market report on the global analytical standards market for the historical period of 2017 - 2018 and forecast period of 2019 - 2027, rise in the number of researches in the life science industry and increase in regulations regarding pharmaceutical and biotechnology manufacturing are anticipated to drive the global market over the period of forecast
Multiplex Assays Market: The global multiplex assays market is anticipated to reach US$ 4,277.31 Mn by 2026, expanding at a CAGR of 7.90% from 2018 to 2026. Expansion of the market can be attributed to the advantages offered by multiplex assays over singleplex assays, rising prevalence of infectious diseases and cancer that can be detected easily at earlier stages, government and private funding for carrying out research, and strategic acquisitions among market players to enhance the reach of the multiplex assay kits
Biotherapeutics Cell Line Development Market: Regulatory changes, introduction of new technologies, and advent of an array of innovative concepts have played a key role in influencing the overall growth of the global biotherapeutics cell line development market over the past few years– a trend that is expected to continue during the forecast period
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."